Celldex Therapeutics Inc Sustainability Reports
Celldex Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on exploring the science of mast cell biology and developing targeted therapeutic antibodies. The company researches and advances monoclonal and bispecific antibodies to treat severe inflammatory, allergic, and autoimmune diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900F018DMYWH38923
FIGI: BBG001S7QN20
4 reports from 2010 to 2024
